* Champions Oncology Inc CSBR.OQ CSBR.O is expected
to show a
rise in quarterly revenue when it reports results on December
11 for the period ending October 31 2024
* The Hackensack New Jersey-based company is expected to
report a
12.8% increase in revenue to $13.054 million from $11.57 million
a year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Champions Oncology Inc
is for
earnings of 1 cent per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Champions
Oncology Inc is $6.00, above its last closing price of $4.34.
This summary was machine generated December 6 at 21:03 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)